REGENXBIO
RGNX
7,28 €
Share price
-4.32%
Change (1 day)
-45.13%
Change (1 year)
Categories
REGENXBIO (RGNX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : €0.18 Billion
According to REGENXBIO's latest financial reports the company's total liabilities are €0.18 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
REGENXBIO - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | €0.19 B | -16.41% |
| 2023-12-31 | €0.23 B | -19.75% |
| 2022-12-31 | €0.29 B | -4.25% |
| 2021-12-31 | €0.30 B | 14.92% |
| 2020-12-31 | €0.26 B | 530.73% |
| 2019-12-31 | €42.59 M | 39.34% |
| 2018-12-31 | €30.56 M | 134.36% |
| 2017-12-31 | €13.04 M | 24.76% |
| 2016-12-31 | €10.45 M | 149.98% |
| 2015-12-31 | €4.18 M | -44.66% |
| 2014-12-31 | €7.55 M | 124.25% |
| 2013-12-31 | €3.36 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | €20.01 M | -89.33% | 🇺🇸 USA |